Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
September 17, 2005
A comparison of pegfilgrastim and filgrastim
Andrew P Grigg
Clinical Lymphoma
|
January 13, 2004
Primary adrenal lymphoma
Andrew P Grigg, Joseph M Connors
European Journal of Haematology
|
September 13, 2002
Aplastic anemia as a late complication of thymoma in remission
David S Ritchie, Craig Underhill, Andrew P Grigg
Leukemia & Lymphoma
|
April 6, 2004
Fatal anerobic bacteremia after hematopoietic stem cell transplant
Monica A Slavin, Andrew P Grigg, Anthony P Schwarer
Cancer
|
February 22, 2002
Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma
John F Seymour, Andrew P Grigg, Jeff Szer, et al.
Blood Reviews
|
April 2, 2018
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
Joel C Wight, Geoffrey Chong, Andrew P Grigg, et al.
Leukemia Research
|
April 11, 2022
Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission
Phillip C Nguyen, Vanessa Donati, Catherine Vassili, et al.
Leukemia & Lymphoma
|
March 24, 2018
An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma
Joel C Wight, Eliza A Hawkes, Salvatore U Berlangieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2018
Management of Pregnancy in Women With Chronic Myeloid Leukemia
David M Ross, Kate L Burbury, Andrew P Grigg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 19, 2003
Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan
David S Ritchie, James Morton, Jeff Szer, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Clinical Advances in Hematology & Oncology : H&O
|
September 17, 2005
A comparison of pegfilgrastim and filgrastim
Andrew P Grigg
Clinical Lymphoma
|
January 13, 2004
Primary adrenal lymphoma
Andrew P Grigg, Joseph M Connors
European Journal of Haematology
|
September 13, 2002
Aplastic anemia as a late complication of thymoma in remission
David S Ritchie, Craig Underhill, Andrew P Grigg
Leukemia & Lymphoma
|
April 6, 2004
Fatal anerobic bacteremia after hematopoietic stem cell transplant
Monica A Slavin, Andrew P Grigg, Anthony P Schwarer
Cancer
|
February 22, 2002
Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma
John F Seymour, Andrew P Grigg, Jeff Szer, et al.
Blood Reviews
|
April 2, 2018
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
Joel C Wight, Geoffrey Chong, Andrew P Grigg, et al.
Leukemia Research
|
April 11, 2022
Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission
Phillip C Nguyen, Vanessa Donati, Catherine Vassili, et al.
Leukemia & Lymphoma
|
March 24, 2018
An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma
Joel C Wight, Eliza A Hawkes, Salvatore U Berlangieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2018
Management of Pregnancy in Women With Chronic Myeloid Leukemia
David M Ross, Kate L Burbury, Andrew P Grigg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 19, 2003
Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan
David S Ritchie, James Morton, Jeff Szer, et al.
Page
of 4